Publication | Closed Access

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyCombination TherapyEarly Viral KineticsEffective PredictionAntiviral DrugLiver DiseaseMedicineEpidemiology